Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH) With Fibrosis”

174 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 174 results

Testing effectiveness (Phase 2)UnknownNCT04880187
What this trial is testing

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Axcella Health, Inc 273
Testing effectiveness (Phase 2)Looking for participantsNCT07481734
What this trial is testing

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Who this might be right for
Metabolic Associated Steatotic Liver DiseaseNonalcoholic SteatohepatitisHepatic Steatosis
Hudson Biotech 120
Testing effectiveness (Phase 2)Looking for participantsNCT06920043
What this trial is testing

Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisNon-alcoholic Fatty Liver Disease
GlaxoSmithKline 42
Not applicableStudy completedNCT02880189
What this trial is testing

EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity

Who this might be right for
ObesityNon-Alcoholic Steatohepatitis
Mayo Clinic 21
Early research (Phase 1)Study completedNCT04857437
What this trial is testing

Study in Healthy Adults Evaluating PF-07202954

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Fibrosis
Pfizer 12
Not applicableLooking for participantsNCT05728697
What this trial is testing

Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisObesity
Brigham and Women's Hospital 150
Testing effectiveness (Phase 2)Study completedNCT05623189
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Type 2 Diabetes
HighTide Therapeutics (Hong Kong) Limited 218
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Very early researchUnknownNCT06348563
What this trial is testing

AGED Diagnostics Liver Disease Assessment

Who this might be right for
NASH With FibrosisNAFLDHealthy
Active Genomes Expressed Diagnostics, Corp 400
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Not applicableStudy completedNCT06024681
What this trial is testing

Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseFecal Microbiota Transplantation
Imperial College London 16
Not applicableLooking for participantsNCT05046483
What this trial is testing

Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI

Who this might be right for
ST-segment Elevation Myocardial Infarction (STEMI)Diabetes MellitusInsulin Resistance+1 more
German Diabetes Center 300
Testing effectiveness (Phase 2)Study completedNCT00856869
What this trial is testing

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

Who this might be right for
Hepatic CirrhosisNonalcoholic Steatohepatitis
Norgine 52
Not applicableUnknownNCT05908006
What this trial is testing

Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
GI Alliance 100
Post-approval studies (Phase 4)Active Not RecruitingNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Not applicableWithdrawnNCT03538236
What this trial is testing

Intragastric Balloon With Lifestyle Intervention vs. Lifestyle Intervention in Obese Patients With NASH

Who this might be right for
ObesityNASH - Nonalcoholic SteatohepatitisObesity, Morbid
Johns Hopkins University
Testing effectiveness (Phase 2)Study completedNCT05638737
What this trial is testing

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Who this might be right for
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AstraZeneca 112
Early research (Phase 1)Study completedNCT01899859
What this trial is testing

Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Galectin Therapeutics Inc. 31
Large-scale testing (Phase 3)Active Not RecruitingNCT05500222
What this trial is testing

Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Who this might be right for
NASHCirrhosis, Liver
Madrigal Pharmaceuticals, Inc. 845
Next Page